Suppression of feeding, drinking, and locomotion by a putative cannabinoid receptor 'silent antagonist'

European Journal of Pharmacology

Volumn 530, Issue 1-2, 2006, Pages 103-106

  Gardner, Andrew ^a   Mallet, Paul E ^a,b  

^a UNIVERSITY OF NEW ENGLAND   (Australia)

^b WILFRID LAURIER UNIVERSITY   (Canada)

Author keywords

(Rat); Body weight; Cannabinoid; Drinking behaviour; Feeding behaviour; Motor activity

Indexed keywords

3 (1 METHANESULFONYLAMINO 4 HEXYN 6 YL) 6A,7,10,10A TETRAHYDRO 6,6,9 TRIMETHYL 6H DIBENZO[B,D] PYRAN; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; O 2050; PYRAN DERIVATIVE; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG POTENTIATION; FEEDING BEHAVIOR; FLUID INTAKE; FOOD INTAKE; HABITUATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TIME;

ANIMALS; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; DRINKING BEHAVIOR; FEEDING BEHAVIOR; INJECTIONS, INTRAPERITONEAL; MALE; MOTOR ACTIVITY; PIPERIDINES; PYRANS; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; TETRAHYDROCANNABINOL; TIME FACTORS;

EID: 29844447996     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.11.032     Document Type: Article

References (14)

1. G.R. Colombo, R. Agabio, G. Diaz, C. Lobina, R. Reali, and G.L. Gessa Appetite suppression and weight loss after the cannabinoid antagonist SR141716 Life Sci. 63 1998 PL113 PL117
2. V. Di Marzo, and I. Matias Endocannabinoid control of food intake and energy balance Nat. Neurosci. 8 2005 585 589
3. V. Di Marzo, S.K. Goparaju, L. Wang, J. Liu, S. Batkai, Z. Jarai, F. Fezza, G.I. Miura, R.D. Palmiter, T. Sugiura, and G. Kunos Leptin-regulated endocannabinoids are involved in maintaining food intake Nature 410 2001 822 825
4. T.C. Kirkham, C.M. Williams, F. Fezza, and V. Di Marzo Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol Br. J. Pharmacol. 136 2002 550 557
5. 1 receptors Life Sci. 76 2005 1307 1324
6. M.C. Sañudo-Peña, J. Romero, G.E. Seale, J. Fernandez-Ruiz, and J.M. Walker Activational role of cannabinoids on movement Eur. J. Pharmacol. 391 2000 269 274
7. L.F. Van Gaal, A.M. Rissanen, A.J. Scheen, O. Ziegler, and S. Rossner Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study Lancet 365 2005 1389 1397
8. A.N.A. Verty, M.E. Singh, I.S. McGregor, and P.E. Mallet The cannabinoid receptor antagonist SR 141716 attenuates overfeeding induced by systemic or intracranial morphine Psychopharmacology 168 2003 314 323
9. 1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake Endocrinology 145 2004 3224 3231
10. 1 cannabinoid and oxytocin receptors in food and water intake Neuropharmacology 47 2004 593 603
11. 9- tetrahydrocannabinol Brain Res. 1020 2004 188 195
12. A.N.A. Verty, I.S. McGregor, and P.E. Mallet A cannabinoid receptor antagonist in non-deprived rats equally suppresses consumption of high carbohydrate, high fat, and normal chow Neurosci. Lett. 354 2004 217 220
13. N.A. Werner, and J.E. Koch Effects of the cannabinoid antagonists AM281 and AM630 on deprivation-induced intake in Lewis rats Brain Res. 967 2003 290 292
14. 1) receptors Psychopharmacology 143 1999 315 317